Inflammation of the ileum, potentially exacerbated by altered gut motility or local mucosal irritation, could have led to a state of functional obstruction or pseudo-obstruction
How might this approach be integrated into broader treatment strategies for thyroid cancer
Food and Drug Administration (FDA) on the 1st approved 'Foundayo (ingredient name: orforglipron),' an oral obesity treatment developed by Eli Lilly, the company that supplies the obesity drug 'Mounjaro.' This is the second oral GLP-1 class obesity treatment to be approved, following the pill form of Novo Nordisk's 'Wegovy' last December
Interestingly, free glutamine and glutamate are reported to exhibit immunomodulating capacities, indicating that these FAAs could contribute to neonatal immune development and to the unique protective effects of breastfeeding
sobre el sistema digestivo, enlenteciendo el vaciado gstrico y disminuyendo la motilidad intestinal
Contact Dermat 78(3):194198